Type: rating_drop

Analysts UBS lowered Zealand Pharma (ZEAL) price target to 540 Danish kroner amid concerns over survodutide’s tolerability

06/18/2026, 10:36 PM business rating_drop Analysts: analysts, UBS biotech

Zealand Pharma's stock has faced significant declines following disappointing data on its weight loss drug survodutide, leading analysts to reduce sales forecasts and shift focus to its other drug, petrelintide, which may offer better prospects in the obesity market.

BMW (BMW.DE) Shares Hit 5-Year Low Following Profit Warning Amid China Slowdown and Iran War

06/17/2026, 05:36 AM rating_drop Analysts: analysts, Citi auto

BMW's shares fell to a five-year low after the company lowered its profit outlook for 2026, primarily due to declining demand in China and rising costs linked to the Iran war, raising concerns about the broader European auto sector.

Analysts CFRA initiate coverage of SpaceX (SPACE) with a sell rating and a 12-month price target of $115, citing elevated valuation concerns

06/15/2026, 01:37 AM economy rating_drop Analysts: analysts, CFRA ai

SpaceX's shares surged in premarket trading following a historic IPO, raising questions about the sustainability of its high valuation amidst significant losses and varying analyst opinions.

Analysts CFRA assigned a sell rating to SpaceX (SPCX) with a 12-month price target of $115, citing elevated valuation expectations

06/12/2026, 10:37 AM investing rating_drop Analysts: analysts, CFRA ai

CFRA has issued a sell rating for SpaceX shortly after its Nasdaq debut, setting a 12-month price target significantly below its initial offering price, highlighting concerns over the company's high valuation and reliance on the success of its Starship rocket.

Analysts Stifel, Wolfe Research, and Evercore ISI downgrade Adobe (ADBE) amid CFO departure and disappointing revenue outlook

06/12/2026, 04:36 AM investing rating_drop Analysts software

Adobe's recent fiscal second-quarter results exceeded expectations, but the stock is facing pressure from executive changes and multiple analyst downgrades, signaling potential challenges ahead for the company.

Analysts RBC Capital Markets downgraded Nike (NKE) to Hold and reduced price target to $50 amid slow turnaround efforts

06/10/2026, 12:37 PM business rating_drop Analysts: analysts, RBC Capital Markets consumer

Nike's stock has significantly underperformed this year, prompting analysts to downgrade the company amid concerns over the slow pace of its turnaround efforts under CEO Elliott Hill. Investors are increasingly anxious about the company's ability to recover, especially with disappointing forecasts for its China revenue.

Analysts RBC downgraded Nike (NKE) to sector perform due to slower-than-expected turnaround under CEO Elliott Hill

06/10/2026, 04:32 AM investing rating_drop Analysts: analysts consumer

RBC has downgraded Nike's stock rating due to concerns that the company's turnaround under CEO Elliott Hill is progressing more slowly than anticipated, impacting its future outlook.

Broadcom (AVGO) Misses Revenue Expectations, Shares Drop 15% Amid AI Sales Forecast Concerns

06/04/2026, 05:33 AM economy rating_drop semiconductors

The S&P 500 has halted its nine-week winning streak due to rising oil prices and Treasury yields, while significant corporate developments include Broadcom's disappointing earnings and SpaceX's upcoming IPO at a valuation of $1.77 trillion.

Analysts Oppenheimer downgraded AT&T (T) to Perform due to competition from SpaceX’s upcoming IPO and satellite broadband threat

06/03/2026, 06:33 AM investing rating_drop Analysts: analysts, Oppenheimer telecom

Oppenheimer's downgrade of AT&T reflects growing concerns about competition from satellite internet providers like SpaceX's Starlink, which could disrupt traditional broadband markets. This shift may pose significant risks for AT&T and similar companies as regulatory support for satellite technology increases.

Analysts Goldman Sachs downgraded Hong Kong stocks to market-weight in favor of mainland China AI hardware investments

06/02/2026, 07:32 PM business rating_drop Analysts: analysts, Goldman Sachs ai tech

Goldman Sachs has shifted its investment preference from Hong Kong stocks to mainland Chinese stocks, particularly in the AI hardware sector, indicating a strategic pivot that could influence investor sentiment and market dynamics.